Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study

NCT ID: NCT06759805

Last Updated: 2025-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-06

Study Completion Date

2035-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In Norway, more than 11,000 patients undergo percutaneous coronary intervention (PCI) annually. However, a very recent study utilizing registry data show a national average of cardiac rehabilitation (CR) participation of only 14%, despite its proven beneficial effects on readmissions, physical capacity, psychological distress, self-management, and quality of life. CR is strongly recommended in European guidelines. However, uptake is low and is not systematically identifying those in most need of CR. The primary objective of eCardiacRehab is to meet rehabilitation needs of large patient populations regardless of their access to traditional place-based rehabilitation by developing and evaluating the efficacy and cost effectiveness of an interdisciplinary and comprehensive home-based eCardiacRehab programme. eCardiacRehab address patient- and system level challenges in order to increase access to CR. The investigators give particular attention to older patients, women, and those with comorbidities or mental health challenges. Aspects related to continuity of care between specialist and primary care services, health literacy, adherence to treatment, cost effectiveness and ethics are investigated. The investigators will 1) continue to develop the programme with patients, general practitioners, healthcare experts from both specialist and primary care services, and technology developers, 2) develop treatment modules, 3) establish information and communication infrastructure, 4) evaluate the process and efficacy of treatment modules, 5) ensure knowledge development and transfer of competence to the municipalities, and 6) contribute to fulfil the innovation potential for health service and industry partners. eCardiacRehab has the potential to improve interaction and collaboration between primary and secondary care, modernise and digitalise work processes, and develop more coherent and tailored patient pathways. The vision of the home-based eCardiacRehab is to make CR available to all.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Cardiac Rehabilitation Ethics Continuity of Patient Care Older Adults (65 Years and Older) Cost-Benefit Analysis Adherence, Medication Adherence, Treatment Health Literacy eHealth Literacy Mental Health Secondary Prevention of Coronary Heart Disease Comorbidities Hypertension Physical Activity Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Usual care

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention group

Digital cardiac rehabilitation

Group Type OTHER

eCardiacRehab

Intervention Type OTHER

Interdisciplinary supervised home-based digital secondary prevention programme (12-week programme) based on the European Society of Cardiology guidelines for cardiac rehabilitation for patients after percutaneous coronary intervention.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

eCardiacRehab

Interdisciplinary supervised home-based digital secondary prevention programme (12-week programme) based on the European Society of Cardiology guidelines for cardiac rehabilitation for patients after percutaneous coronary intervention.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult Norwegian (or Scandinavian) speaking patients (≥ 18 years) who have a Norwegian national identification number,
* With coronary artery disease after percutaneous coronary intervention
* Are living at home and have internet available to them
* Providing signed informed consent

Exclusion Criteria

* Patients with cognitive impairment that may interfere with the ability to comply with the study protocol
* Severe aortic stenosis
* Severe arrhythmias
* Expected lifetime less than one year as determined by study personnel
* Otherwise clinically unstable
* Not fully revascularized (awaits percutaneous coronary intervention or coronary artery bypass graft surgery)
* Inability to comply with the study protocol due to any physical disability, somatic disease, or mental problems as determined by study personnel
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Research Council of Norway

OTHER

Sponsor Role collaborator

Helse Vest

OTHER

Sponsor Role collaborator

Helse Fonna

OTHER

Sponsor Role collaborator

Helse Møre og Romsdal HF

OTHER_GOV

Sponsor Role collaborator

Helse Vest IKT

UNKNOWN

Sponsor Role collaborator

Western Norway University of Applied Sciences

OTHER

Sponsor Role collaborator

Youwell

UNKNOWN

Sponsor Role collaborator

University of Bergen

OTHER

Sponsor Role collaborator

Østfold University College

UNKNOWN

Sponsor Role collaborator

Norsk råd for digital etikk

UNKNOWN

Sponsor Role collaborator

Helse Førde HF

UNKNOWN

Sponsor Role collaborator

University of Amsterdam

OTHER

Sponsor Role collaborator

Center for Research on Cardiac Disease in Women

UNKNOWN

Sponsor Role collaborator

Nasjonal kompetansetjeneste Trening som medisin

UNKNOWN

Sponsor Role collaborator

RELIS Vest

UNKNOWN

Sponsor Role collaborator

Norwegian Centre for E-health Research

UNKNOWN

Sponsor Role collaborator

Bergen Municipality

UNKNOWN

Sponsor Role collaborator

Sunnfjord Municipality

UNKNOWN

Sponsor Role collaborator

Sogndal Municipality

UNKNOWN

Sponsor Role collaborator

Masfjorden Municipality

UNKNOWN

Sponsor Role collaborator

The Norwegian Heart and Lung Patient Organization

UNKNOWN

Sponsor Role collaborator

E-helse Vestland

UNKNOWN

Sponsor Role collaborator

Yale University

OTHER

Sponsor Role collaborator

University of Sydney

OTHER

Sponsor Role collaborator

University of Cambridge

OTHER

Sponsor Role collaborator

University of Regina

OTHER

Sponsor Role collaborator

University of Copenhagen

OTHER

Sponsor Role collaborator

Linkoeping University

OTHER_GOV

Sponsor Role collaborator

Voss Hospital, Norway

UNKNOWN

Sponsor Role collaborator

Haukeland University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tone M Norekvål, PhD

Role: PRINCIPAL_INVESTIGATOR

Haukeland University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Haukeland University Hospital

Bergen, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Trond R Pettersen, PhD

Role: CONTACT

004748124938

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Trond R Pettersen, PhD

Role: primary

004748124938

References

Explore related publications, articles, or registry entries linked to this study.

Brors G, Pettersen TR, Hansen TB, Fridlund B, Holvold LB, Lund H, Norekval TM. Modes of e-Health delivery in secondary prevention programmes for patients with coronary artery disease: a systematic review. BMC Health Serv Res. 2019 Jun 10;19(1):364. doi: 10.1186/s12913-019-4106-1.

Reference Type BACKGROUND
PMID: 31182100 (View on PubMed)

Valaker I, Fridlund B, Wentzel-Larsen T, Nordrehaug JE, Rotevatn S, Raholm MB, Norekval TM. Continuity of care and its associations with self-reported health, clinical characteristics and follow-up services after percutaneous coronary intervention. BMC Health Serv Res. 2020 Jan 31;20(1):71. doi: 10.1186/s12913-020-4908-1.

Reference Type BACKGROUND
PMID: 32005235 (View on PubMed)

Norekval TM, Allore HG, Bendz B, Bjorvatn C, Borregaard B, Brors G, Deaton C, Falun N, Hadjistavropoulos H, Hansen TB, Igland S, Larsen AI, Palm P, Pettersen TR, Rasmussen TB, Schjott J, Sogaard R, Valaker I, Zwisler AD, Rotevatn S; CONCARD Investigators. Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARDPCI). BMJ Open. 2020 Feb 12;10(2):e031995. doi: 10.1136/bmjopen-2019-031995.

Reference Type BACKGROUND
PMID: 32054625 (View on PubMed)

Norekval TM, Allore HG. Cardiac rehabilitation in older adults: is it just lifestyle? Heart. 2020 Jul;106(14):1035-1037. doi: 10.1136/heartjnl-2019-316497. Epub 2020 Apr 16. No abstract available.

Reference Type BACKGROUND
PMID: 32299827 (View on PubMed)

Brors G, Dalen H, Allore H, Deaton C, Fridlund B, Osborne RH, Palm P, Wentzel-Larsen T, Norekval TM; CONCARD investigators. Health Literacy and Risk Factors for Coronary Artery Disease (From the CONCARDPCI Study). Am J Cardiol. 2022 Sep 15;179:22-30. doi: 10.1016/j.amjcard.2022.06.016. Epub 2022 Jul 16.

Reference Type BACKGROUND
PMID: 35853782 (View on PubMed)

Brors G, Dalen H, Allore H, Deaton C, Fridlund B, Norman CD, Palm P, Wentzel-Larsen T, Norekval TM. The association of electronic health literacy with behavioural and psychological coronary artery disease risk factors in patients after percutaneous coronary intervention: a 12-month follow-up study. Eur Heart J Digit Health. 2023 Feb 7;4(2):125-135. doi: 10.1093/ehjdh/ztad010. eCollection 2023 Mar.

Reference Type BACKGROUND
PMID: 36974270 (View on PubMed)

Instenes I, Fridlund B, Borregaard B, Larsen AI, Allore H, Bendz B, Deaton C, Rotevatn S, Falun N, Norekval TM. 'When age is not a barrier': an explorative study of nonagenarian patients' experiences of undergoing percutaneous coronary intervention. Eur J Cardiovasc Nurs. 2024 Sep 5;23(6):608-617. doi: 10.1093/eurjcn/zvad132.

Reference Type BACKGROUND
PMID: 38243638 (View on PubMed)

Hjertvikrem N, Brors G, Instenes I, Helmark C, Pettersen TR, Rotevatn S, Zwisler ADO, Norekval TM; CONCARDPCI Investigators. Use of health services and perceived need for information and follow-up after percutaneous coronary intervention. BMC Res Notes. 2024 Jan 5;17(1):20. doi: 10.1186/s13104-023-06662-y.

Reference Type BACKGROUND
PMID: 38183067 (View on PubMed)

Ferrel-Yui D, Candelaria D, Pettersen TR, Gallagher R, Shi W. Uptake and implementation of cardiac telerehabilitation: A systematic review of provider and system barriers and enablers. Int J Med Inform. 2024 Apr;184:105346. doi: 10.1016/j.ijmedinf.2024.105346. Epub 2024 Jan 24.

Reference Type BACKGROUND
PMID: 38281451 (View on PubMed)

Norekval TM, Bale M, Bedane HK, Hole T, Ingul CB, Munkhaugen J. Cardiac rehabilitation participation within 6 months of discharge in 37 136 myocardial infarction survivors: a nationwide registry study. Eur J Prev Cardiol. 2024 Nov 18;31(16):1977-1980. doi: 10.1093/eurjpc/zwad350. No abstract available.

Reference Type BACKGROUND
PMID: 37943676 (View on PubMed)

Pettersen TR, Schjott J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos HD, Larsen AI, Nordrehaug JE, Rasmussen TB, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekval TM; CONCARD Investigators. Discharge Information About Adverse Drug Reactions Indicates Lower Self-Reported Adverse Drug Reactions and Fewer Concerns in Patients After Percutaneous Coronary Intervention. Heart Lung Circ. 2024 Mar;33(3):350-361. doi: 10.1016/j.hlc.2023.12.005. Epub 2024 Jan 18.

Reference Type BACKGROUND
PMID: 38238118 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

344337

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

F-12624

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

R-10930

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

459136

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.